Wellington Management Group LLP Apellis Pharmaceuticals, Inc. Transaction History
Wellington Management Group LLP
- $531 Billion
- Q4 2024
A detailed history of Wellington Management Group LLP transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 11,800,849 shares of APLS stock, worth $335 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
11,800,849
Previous 15,566,969
24.19%
Holding current value
$335 Million
Previous $449 Million
16.12%
% of portfolio
0.07%
Previous 0.08%
Shares
21 transactions
Others Institutions Holding APLS
# of Institutions
302Shares Held
123MCall Options Held
2.63MPut Options Held
845K-
Avoro Capital Advisors LLC New York, NY12.2MShares$346 Million5.68% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$337 Million17.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$285 Million0.01% of portfolio
-
Morgan Stanley New York, NY9.63MShares$273 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$164 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.11B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...